
NovAliX, a drug discovery-focused contract research organisation, and Chemical.AI, an artificial intelligence (AI) company, have announced a strategic collaboration in …
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns
How will biomarker-led diagnostics reshape respiratory medicine?

